Catriona Jamieson, MD, PhD, is a board-certified hematologist with broad clinical expertise caring for patients with hematologic malignancies. Her research explores the fundamental question of how space alters cancer progression. Her ultimate mission: to discover life-saving therapies for cancer that tackle the root cause of the disease, and to advance therapeutics that enhance stem-cell regeneration.
Jamieson serves as a professor of medicine at the University of California San Diego School of Medicine and the chief of its Division of Regenerative Medicine; director of the university’s Sanford Stem Cell Institute; and co-leader of its Hematologic Malignancies Program. She is also the university’s Sanford Stem Cell Institute Chancellor’s Endowed Chair in Regenerative Medicine.
Aside from publishing more than 100 articles in journals like The New England Journal of Medicine, Nature, Cancer Discovery, Blood and Cell Stem Cell, her work has been featured on CNN, BBC, TIME, Reuters, NBC News, CBS News, Fortune, The Washington Post and The Hill, to name a few. She completed both her MD and her PhD in microbiology at the University of British Columbia in Vancouver, British Columbia, Canada.
The new frontier of cancer research is in space
In the microgravity of space, tumors can triple in size in just 10 days. That could be a boon for cancer research, and a risk for astronauts.